Authors' response to the Letter to the Editor regarding: Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations.
作者信息
D'Amato Gennaro, Acanfora Luca, Paoli Lucrezia Delli, D'Amato Maria
机构信息
Division of Respiratory and Allergic Diseases, Department of Chest Diseases, High Specialty "A. Cardarelli" Hospital, Naples.
Managing Director of the Covid-19 nasopharyngeal testing project, for the cooperation agreement between High Specialization in Infectious Diseases "Cotugno Hospital" and "Sovereign Military of Malta" in Naples, Federico II University of Naples.
出版信息
Multidiscip Respir Med. 2021 Apr 13;16(1):768. doi: 10.4081/mrm.2021.768. eCollection 2021 Jan 15.
Abstract
摘要
相似文献
1
Authors' response to the Letter to the Editor regarding: Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations.作者对致编辑的信的回复，主题为：针对感染新型冠状病毒肺炎并有症状患者的预防性家庭治疗及随后的远程会诊
Multidiscip Respir Med. 2021 Apr 13;16(1):768. doi: 10.4081/mrm.2021.768. eCollection 2021 Jan 15.
2
Comments on "Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations" by D'Amato .对达马托所著《COVID-19 症状患者的预防性家庭治疗及远程会诊跟踪》的评论
Multidiscip Respir Med. 2021 Apr 8;16(1):757. doi: 10.4081/mrm.2021.757. eCollection 2021 Jan 15.
3
Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations.为感染新冠病毒的有症状患者提供预防性家庭治疗，并进行远程会诊。
Multidiscip Respir Med. 2021 Jan 18;16(1):748. doi: 10.4081/mrm.2021.748. eCollection 2021 Jan 15.
4
Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.作者对编辑来信的回复，编辑来信：作者对编辑来信的回复：日本人类乳头瘤病毒免疫接种的安全性问题：名古屋市不良事件监测数据的分析与评估
Jpn J Nurs Sci. 2020 Jan;17(1):e12310. doi: 10.1111/jjns.12310. Epub 2019 Dec 2.
5
Authors' response to a letter to the editor IJPORL-D-20-01778: Response to a Letter to the Editor.作者对致编辑的一封信（IJPORL-D-20-01778）的回复：对致编辑信件的回复
Int J Pediatr Otorhinolaryngol. 2021 Jan 28:110633. doi: 10.1016/j.ijporl.2021.110633.
6
Authors' response to the Letter to the Editor regarding: Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up.作者对关于：新冠后严重感染肺部损害研究。早期三个月多学科随访的经验的来信的回复。
Monaldi Arch Chest Dis. 2022 Mar 4;92(4). doi: 10.4081/monaldi.2022.2244.
7
Perceptions of Patients and Physicians on Teleconsultation at Home for Diabetes Mellitus: Survey Study.糖尿病患者及医生对居家远程会诊的认知：调查研究
JMIR Hum Factors. 2021 Nov 23;8(4):e27873. doi: 10.2196/27873.
8
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病：治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验)：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
9
Letters to the editor in response to studies of guns in the home and homicide and suicide.致编辑的信：回应关于家中枪支与凶杀及自杀的研究
Inj Epidemiol. 2017 Dec;4(1):3. doi: 10.1186/s40621-016-0100-9. Epub 2017 Feb 6.
10
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.维生素K拮抗剂与低分子量肝素用于有症状静脉血栓栓塞症的长期治疗比较
Cochrane Database Syst Rev. 2017 Jul 24;7(7):CD002001. doi: 10.1002/14651858.CD002001.pub3.
本文引用的文献
1
Comments on "Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations" by D'Amato .对达马托所著《COVID-19 症状患者的预防性家庭治疗及远程会诊跟踪》的评论
Multidiscip Respir Med. 2021 Apr 8;16(1):757. doi: 10.4081/mrm.2021.757. eCollection 2021 Jan 15.
2
Safety and Efficacy of Low-Dose Corticosteroids in Patients With Non-severe Coronavirus Disease 2019: A Retrospective Cohort Study.低剂量皮质类固醇对非重症2019冠状病毒病患者的安全性和有效性：一项回顾性队列研究
Cureus. 2021 Jan 7;13(1):e12544. doi: 10.7759/cureus.12544.
3
Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations.为感染新冠病毒的有症状患者提供预防性家庭治疗，并进行远程会诊。
Multidiscip Respir Med. 2021 Jan 18;16(1):748. doi: 10.4081/mrm.2021.748. eCollection 2021 Jan 15.
4
When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19.何时叫停：界定低剂量皮质类固醇在阻止非重症新型冠状病毒肺炎进展中的作用
Ann Med Surg (Lond). 2021 Feb;62:236-238. doi: 10.1016/j.amsu.2021.01.063. Epub 2021 Jan 21.
5
Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.持续性 COVID-19 间质性肺病。皮质类固醇治疗的观察性研究。
Ann Am Thorac Soc. 2021 May;18(5):799-806. doi: 10.1513/AnnalsATS.202008-1002OC.
6
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence.使用依诺肝素对抗新冠病毒感染并减少血栓栓塞性静脉并发症：当前证据综述
Front Pharmacol. 2020 Sep 16;11:579886. doi: 10.3389/fphar.2020.579886. eCollection 2020.
7
Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.短期小剂量糖皮质激素治疗轻症 COVID-19 患者的效果。
Biomed Res Int. 2020 Sep 23;2020:2854186. doi: 10.1155/2020/2854186. eCollection 2020.
8
Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019.新型冠状病毒肺炎不同临床类型患者的临床特征及糖皮质激素的应用。
Sci Rep. 2020 Aug 13;10(1):13689. doi: 10.1038/s41598-020-70387-2.
9
Heparin as a therapy for COVID-19: current evidence and future possibilities.肝素治疗 COVID-19：当前证据和未来可能。
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217. doi: 10.1152/ajplung.00199.2020. Epub 2020 Jun 10.
10
[Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].[接受皮质类固醇治疗的重症 COVID-19 患者的动态炎症反应]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):220-226. doi: 10.3785/j.issn.1008-9292.2020.03.10.
Zotero 插件